Edlain Rodriguez

Rodriguez asked about buyback cadence; Rabbitt reaffirmed ~$600M buybacks plus ~$200M dividends (~$800M total return), with ~$100M repurchased in 1H.

Lewis emphasized can winning across all regions from other substrates. Promotional activity ramping with World Cup and America 250 labels visible in plants globally. Rabbitt noted consumer headwinds drive home consumption shift, benefiting cans.

Lewis confirmed aluminum pass-through is immediate. Other costs (energy, freight) formulaic on annual basis. Rabbitt added freight often paid by customer. Energy costs hedged to align with customer contracts.

Lewis emphasized strategy continuity: execution excellence, customer proximity, accelerating substrate shift to aluminum, and managing complexity. Doubling down on operational and commercial excellence through Ball Business System.

Lewis attributed EMEA leverage to growing into available capacity, which was consumed faster than planned, precipitating the Benepack acquisition. Guided at least 2x operating leverage in EMEA for 2026.

Fisher said Ball is cheap on historical valuation and 5-year outlook. Will be deliberate and consistent in returning value, keeping foot on gas as long as constructive outlook persists.

Fisher expressed confidence, citing team's navigation of Russia exit, light beer marketing dislocation, Argentina crisis, and tariff challenges over 3-4 years. Only concern is unpredictability of geopolitical decisions by world leaders.

Fisher turned concern into positive: reduced C-store traffic from ICE fears drives more at-home multipack purchasing in grocery, which benefits cans. Net positive for can volumes.

Fisher described Europe as tight with incremental capacity being added. May need to accelerate investment timeline if mid-single-digit growth persists. All within capital envelope.

Fisher confident in low end of guidance. Cited defensive/recession-resilient nature of packaging, potential FX tailwinds from weaker dollar, and team's track record navigating challenges.

Yu confirmed accelerated buyback pace, already $290M year-to-date, and expects to exceed $1.3B target for 2025.

Fisher dismissed alcohol health concerns as noise relative to near-term consumer spending pressure. Noted beer is growing everywhere else globally. Not a 3-5 year risk.

Bohn signaled continued opportunistic buybacks given ample cash and undervalued shares; Frost attributed the Q2 US price dip to trader liquidation, with prices recovering to the $400-$415 level.

Bert argued best thing for farmers would be corn price rally driven by under-application elsewhere or weather events. Does not expect nitrogen application cuts in North America given yield opportunity on dry and irrigated land. Fall 2025 ammonia season was extremely good and spring 2026 ammonia season also very good, indicating farmer planning and lower-cost product purchased earlier. 2025 yield was approximately 187 bushels per acre.

Bert acknowledged farmer economics as important part of value chain, studying return on variable and full costs across major crops. Noted government direct payments are helpful for balance of payments but acknowledged credit issues in certain US regions that retailers are managing. Positioned CF as wanting to be part of the solution for farmers.

Tony attributed valuation gap to automated sector-level trading not recognizing CF's differentiated financials. Argued continued share buybacks at depressed valuations eventually force re-rating. Chris said strategy is to continue executing on operational performance and free cash flow conversion.

Bert argued supply constrained by global conflicts, plant outages and gas limitations while demand growing 1-2% annually. China's 4M export tons needed by world market. India underperforming domestic production targets. Tony quipped analysts provide the bearish counterpoints.

Bert argued land rent at $200-$400 per acre is the key cost lever, not nitrogen which is a smaller portion of the 25% input cost share. Tony added farmers will optimize yield with nitrogen since last few bushels determine profitability.

Bert gave differentiated view: corn inventories at decade lows globally but farm-gate economics not as positive as prior years due to input costs and land rent. Corn preferred over soybeans given crush margin weakness. Brazil and Argentina growing with policy support.

Bert acknowledged risks on both sides but emphasized tight fundamentals: strong demand from crop economics, constrained supply, expanding NOLA-Midwest differentials.

Magro said high single digit Brazil pricing pressure is not the new normal, citing growing demand, healthy channel and a strong new-product pipeline.

Chuck said markets are structurally different with unique buying and channel dynamics. China may be taking early steps to control exports by repealing export VAT which will raise export costs. M&A among Chinese generics is also constructive. Expects 2026 to see slow global growth, better than last 3 years.

Chuck said $10M EBITDA per 1M acre corn-to-soy shift, already factored into $4.1B 2026 outlook. Logical to expect 2-3M acres shifting back to soybeans but not disruptive given market-leading position in both.

Chuck said farmer margins are tight but farmers continue investing in technology for yield gains. Price-for-value strategy works because a few bushels per acre can make the difference between profit and loss.

Chuck said crop prices moderated and farmer margins tightened slightly in the US but remain strong in Brazil. Watching H2 export windows and CP pricing. Farmers investing in technology despite tighter margins.

Judd said competitive supply is settling out with safrinha acres increasing. For 2025, COGS position materially improves and pricing opportunity exists with better technology.

Bodine expects a mix of rising crop prices and shifting raw-material costs, with no preference stated. Up to 30 million tonnes of lost production and multi-year under-application should pressure yields and lift crop prices; corn above $5 would boost sentiment.

Bodine described unprecedented simultaneous compression of producer margins and farmer affordability. At $1,200 sulfur, most of the producer cost curve is underwater. Situation self-correcting: Strait of Hormuz will eventually normalize, under-application will drive yield impacts and demand recovery, ag commodity prices already rising. Americas most pressured while Asia subsidized markets remain active. Temporary production curtailments by Mosaic and globally are the market's response.

Wang confirmed farmers unusually applied potash without phosphate in November-December, driven by potash affordability being much better than phosphate. Two factors suppressed Q4 demand: government payment timing uncertainty and weather cutting off late application windows. Demand was also constrained by supply with US phosphate imports down over 1 million tons YTD.

Bodine emphasized supply-demand fundamentals drive pricing, not ag economics alone. Phosphate constrained by Chinese domestic demand (ag + LFP) with no new capacity before 2028. Potash constructive with BHP delayed, limited Laos additions. Wang added ag economics variable globally, China and India government-supported, Americas pressured. Chinese phosphate exports to decline 1.5M+ tons for full year.

Bodine noted phosphate stripping margins are protracted at high levels but potash has better EBITDA-to-cash conversion due to lower CapEx demands. Declined to choose between the two segments. Luciano added that phosphate operating leverage is huge in cycle upturns, tending to surprise on cash flow generation upside.

Bodine attributed potash price appreciation to supply-side changes since December: ~1.5M tons removed through Chinese domestic production cuts, Laos sinkhole issues, and FSU maintenance announcements. Prices up >$40/ton since year-end.

Masters said stationary storage is about 25% of lithium demand growing at 2x the EV rate, but EVs will remain the larger market long term.

Erik sized external Fragrance Ingredients at ~$500M annually, split roughly 50/50 specialty and commodity. Specialty being emphasized with R&D pipeline across naturals, synthetics, and biotech molecules. Commodity side being deemphasized for external sales while maintaining competitive cost for internal formulation use.